RPC

Published on:
Wednesday, August 12, 2015

The REMS Program Companies (RPC) assigns an ID (RPC ID) to each activity for which it provides commercial support.  Accredited providers that offer RPC- supported REMS activities are responsible for entering the RPC ID in the...

Since 2009, the ACCME has supported the role of accredited CME as a strategic asset to US Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategies (REMS), provided the proper...

Here are additional resources to support accredited CME providers that choose to design education to address the goals of the FDA Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and...

Last Revised:
August 27, 2012

In the Extended-Release and Long-Acting Opioid Analgesics REMS, one of the elements to assure safe use is an education program for prescribers about the risks of opioid medications as well as safe prescribing and safe use practices...

Last Revised:
August 27, 2012

The FDA delivered its Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting (ER/LA) opioid analgesics to the manufacturers in 2012.  According to the...